Old drug, new hope for cancer Treatment's painful side effect
NCT ID NCT06617182
Summary
This study is testing whether a combination of two drugs, thalidomide and glutamine, can safely reduce intestinal bleeding in people who developed this complication after radiation therapy for cancer. About 150 adult patients with ongoing bleeding will be randomly assigned to different treatment groups for 8 weeks. Researchers will track how often bleeding occurs and if the treatment helps patients need fewer blood transfusions or hospital visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION ENTERITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Department of Gastroenterology & Hepatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Ch
RECRUITINGXi'an, Shaanxi, 710005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.